Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $3.69 Billion
  • Q4 2024

Orbimed Advisors LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $3.69 Billion distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $401M, Boston Scientific Corp with a value of $282M, Eli Lilly & CO with a value of $261M, Intuitive Surgical Inc with a value of $210M, and Neurocrine Biosciences Inc with a value of $128M.

Examining the 13F form we can see an decrease of $551M in the current position value, from $4.24B to 3.69B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.69 Billion
Healthcare: $3.66 Billion
ETFs: $33.5 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.31B
$117 Million 3.17% of portfolio
963,400
Q4 2024 Added 0.93%
$4.59B
$98.5 Million 2.67% of portfolio
2,817,347
Q4 2024 Added 21.21%
$4.3B
$76.2 Million 2.06% of portfolio
575,000
Q3 2024 Added 64.65%
$4.73B
$74.5 Million 2.02% of portfolio
1,584,005
Q4 2024 Added 106.54%
$2.01B
$51.1 Million 1.38% of portfolio
999,000
Q4 2024 Reduced 4.86%
$3.63B
$45.3 Million 1.23% of portfolio
1,255,031
Q4 2024 Reduced 9.75%
$8.72B
$38.2 Million 1.03% of portfolio
679,816
Q3 2024 Added 1.1%
$2.47B
$37.2 Million 1.01% of portfolio
947,877
Q4 2024 Added 4.0%
$3.12B
$22.4 Million 0.61% of portfolio
400,000
Q4 2024 Reduced 8.24%
$2.58B
$21.5 Million 0.58% of portfolio
2,285,400
Q4 2024 Added 300.74%
$4.82B
$3.68 Million 0.1% of portfolio
23,500
Q3 2024 Reduced 21.58%
$3.55B
$2.16 Million 0.06% of portfolio
78,500
Q4 2024 New
$2.41B
$1.84 Million 0.05% of portfolio
66,000
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $3.69 Billion
  • Prior Value $4.24 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 20 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email